An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tandem Diabetes Care Announces Upcoming Conference Presentation
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leader in diabetes technology, will present a company update at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022, at 9:00 AM Eastern Time. The presentation will be available via live webcast, and an archive will be accessible for 30 days. More details can be found on Tandem's Investor Center under the “Events & Presentations” section. Tandem is known for its innovative insulin delivery solutions, including the t:slim X2 insulin pump.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 9:00am Eastern Time (6:00am Pacific Time).
The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.
